US › Healthcare

Heartbeam Inc (BEAT)

US · Healthcare · Health Information Services

$0.42+2.52%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-5.0M

EPS

$-0.10

EPS estimate

$-0.10

EPS came in at -0.10 against a street estimate of -0.10 — a beat of 0.0%.

Key statistics

Market cap

$23.9M

Forward P/E

0.0

P/B

2.80

Book value

$0.14

EPS (TTM)

$-0.54

52-week high

$4.00

52-week low

$0.39

50-day MA

$0.52

200-day MA

$1.13

Beta

-0.80

Analyst view

Analysts rate Heartbeam Inc a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $3.17.

Shareholding

Insiders

19.57%

Institutions

14.40%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	2.13%
BlackRock Inc	1.59%
Geode Capital Management, LLC	0.67%
Smith, Salley & Associates, LLC	0.65%
UBS Group AG	0.59%
Sigma Planning Corp	0.44%
Beacon Pointe Advisors, LLC	0.44%
Comprehensive Portfolio Management, LLC	0.37%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Heartbeam Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.